Samsung Biologics Plans $2.2 Billion Rights Offering to Fund Peptide Acquisition
South Korean contract manufacturer will issue 2.27 million new shares at discounted price as pharmaceutical industry consolidation accelerates
Every BriefAsia story tagged South Korea, newest first.

South Korean contract manufacturer will issue 2.27 million new shares at discounted price as pharmaceutical industry consolidation accelerates

Investors react to shareholder return plan lacking cancellation details, even as chipmaker pledges record 110 trillion won distribution

The Monetary Authority of Singapore proposed opening access to new fund types in July, but South Korea's recent retail trading crisis underscores the need for investor safeguards

South Korea's memory chip giants are deploying contrasting strategies to distribute AI boom profits, with Samsung favoring dividends while SK hynix pursues aggressive buybacks

A government push to modernize Korea's capital markets turned into a $38.7 billion lesson in the risks of democratizing complex derivatives